Prospects Brighter For 23andMe Holding Co. (ME)
23andMe Holding Co. (NASDAQ: ME) announced a revenue increase in the first quarter of the fiscal year 2023, which concluded on June 30. The genetics specialist broadens the scope of services, but the loss remains significant. 23andMe’s sales increased 9% year on year to $65 million in the first quarter of the fiscal year. The […]